Antidepressants rake in billions

The following is data I found at USAToday.com. Shouldn’t be shocking but I can’t help but think of pharmaceutical execs rolling around in dough, laughing happily at medicating those who find nothing but hopelessness and sadness.

Top-selling antidepressant drugs in 2005:

  • Zoloft: $3.1 billion
  • Effexor XR: $2.6 billion
  • Lexapro: $2.1 billion
  • Wellbutrin XL: $1.5 billion
  • Cymbalta: $667 million

Source: IMS Health
Give Cymbalta time since it’s relatively new to the market. It’ll catch up. I also can’t help but think that the friendly Zoloft ads have helped push its profit margin to first place. The ads are nearly everywhere. Come antidepressant time, it’s the first med that patients think of and probably ask their doctor for.

About these ads

1 Comment

  1. CL Psy said,

    December 15, 2006 at 2:25 pm

    Cymbalta will certainly catch up. Most of its competition is going generic soon, so look for Cymbalta to have some monster sales numbers within a year or two. It is heavily marketed as treating painful physical symptoms that sometimes co-occur with depression, but there is very little evidence to support this claim. Go to their website at http://www.depressionhurts.com and you’ll see what I mean about marketing. Yet if you go to Lilly’s clinical trial database, you will find the data on treating pain in depression very unimpressive. It would appear that the FDA does not care to regulate Cymbalta’s misleading marketing.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 863 other followers

%d bloggers like this: